222 related articles for article (PubMed ID: 18604175)
1. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.
Strizzi L; Abbott DE; Salomon DS; Hendrix MJ
Cell Cycle; 2008 Jul; 7(13):1931-5. PubMed ID: 18604175
[TBL] [Abstract][Full Text] [Related]
2. Role of Cripto-1 in stem cell maintenance and malignant progression.
Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
[TBL] [Abstract][Full Text] [Related]
3. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
[TBL] [Abstract][Full Text] [Related]
4. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
[TBL] [Abstract][Full Text] [Related]
5. The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics.
Strizzi L; Margaryan NV; Gilgur A; Hardy KM; Normanno N; Salomon DS; Hendrix MJ
Cell Cycle; 2013 May; 12(9):1450-6. PubMed ID: 23574716
[TBL] [Abstract][Full Text] [Related]
6. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
Gray PC; Shani G; Aung K; Kelber J; Vale W
Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
[TBL] [Abstract][Full Text] [Related]
7. Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.
Watanabe K; Meyer MJ; Strizzi L; Lee JM; Gonzales M; Bianco C; Nagaoka T; Farid SS; Margaryan N; Hendrix MJ; Vonderhaar BK; Salomon DS
Stem Cells; 2010 Aug; 28(8):1303-14. PubMed ID: 20549704
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
[TBL] [Abstract][Full Text] [Related]
9. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
[TBL] [Abstract][Full Text] [Related]
10. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
[TBL] [Abstract][Full Text] [Related]
11. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
[TBL] [Abstract][Full Text] [Related]
12. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
13. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
Taghizadeh R; Noh M; Huh YH; Ciusani E; Sigalotti L; Maio M; Arosio B; Nicotra MR; Natali P; Sherley JL; La Porta CA
PLoS One; 2010 Dec; 5(12):e15183. PubMed ID: 21203549
[TBL] [Abstract][Full Text] [Related]
14. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
15. CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
[TBL] [Abstract][Full Text] [Related]
16. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
18. Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3.
Hentschke M; Kurth I; Borgmeyer U; Hübner CA
J Biol Chem; 2006 Nov; 281(44):33497-504. PubMed ID: 16954206
[TBL] [Abstract][Full Text] [Related]
19. Nodal/Cripto signaling in fetal male germ cell development: implications for testicular germ cell tumors.
Spiller CM; Bowles J; Koopman P
Int J Dev Biol; 2013; 57(2-4):211-9. PubMed ID: 23784832
[TBL] [Abstract][Full Text] [Related]
20. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.
D'Andrea D; Liguori GL; Le Good JA; Lonardo E; Andersson O; Constam DB; Persico MG; Minchiotti G
J Cell Biol; 2008 Feb; 180(3):597-605. PubMed ID: 18268105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
